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Background: Medications discrepancies are defined as the variations in drug regimens during transition from one 
health care worker or hospital to another.  The elderly diabetic patients are at risk of medication discrepancies due to 
their multiple comorbidities resulting in different medications from the many healthcare providers they are likely to 
see and physiological changes as a result of advanced age; hence the need for medication reconciliation.  
Objectives: The main objective of the study was to measure the prevalence and identify risk factors for medication 
discrepancies at admission of inpatient elderly diabetics at Kenyatta National Hospital (KNH).  
Methods: The study design was cross sectional descriptive study in which patients aged 60 years and above were 
recruited at the time of admission at the medical wards in 2016. Convenient sampling was conducted. A comparison of 
the medication used before and after admission was done to determine the number of discrepancies if any.  Admitting 
clinicians were interviewed to determine if discrepancies were intentional or not. Linear regression was conducted to 
determine risk factors for the number of errors per patient. 
Results: Among the 163 patients recruited, 1089 medication discrepancies were identified, 63.2% of the patients had 
at least one unintentional discrepancy. The number of unintentional discrepancies per patient was 1.5 per patient. 
The most common discrepancy was omissions 236 (98.3%).  Independent risk factors for discrepancies were the 
number of medications prior to admission (adjusted β coefficient 1.377 (95% CI: 0.767, 1.987)), hypertension (β 
0.992 (95% CI: 0.094, 1.890)) and those with discharge forms from other facilities (β 0.701 (95% CI: 0.010, 1.392)). 
Age had a negative association with medication discrepancies (β -0.755 (95% CI: -1.284, -0.226)). 
Conclusion: The prevalence of medication discrepancies was high hence the need for medication reconciliation to 
reduce these discrepancies. 
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1. Introduction 
Medication discrepancies are defined as unexplained 
differences among prescriptions during transition from 
one health care worker or hospital to another 
(Climente-Martí et al, 2010). These medication 
discrepancies are either intentional or unintentional 
and can lead to reconciliation errors which can be 
detrimental to patients (Climente-Martí et al, 2010). 
Intentional discrepancies are not errors but deliberate 
changes in a patient’s medication regimen made by a 
provider. Unintentional discrepancies, however, are 
caused by accidental medication prescribing and are 
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medication errors. They can result in adverse drug 
events (ADEs) if actual harm is caused or (potential 
ADEs) that are near misses and have the potential to 
cause harm (Grossman, 2011). The unintentional 
discrepancies can result in poor management of acute 
and chronic diseases, hospital readmission, and death 
(Grossman, 2011).  
The factors that contribute to medication errors 
include: older age, people with serious and multiple 
health conditions, those taking multiple medications 
and those using high risk medicines (Hilditch, 2012). 
The elderly are at increased risk of medication errors 
due to the following factors: normal ageing; not taking 
medication correctly, multiple chronic illnesses, poly-
pharmacy, taking unnecessary medication through self-
medication, wrong medication for the individual’s 
medical condition, and inappropriate dose (Cameli et al, 
2012).   
Elderly diabetics are a heterogeneous group of patients. 
Some could be living alone, others with care givers 
while others could be in assisted care living. They 
require multiple drugs for their diabetes (DM) and their 
associated comorbidities (Dawn, 2014).  Management of 
type 2 diabetes in the elderly population is difficult 
because of complex comorbidities and the difficulties 
they generally encounter in performing normal daily 
activities (Chau and Edelman,  2001). 
Geriatric syndromes such as cognitive dysfunction, 
limited physical activity, vision and hearing impairment 
occur more often in the elderly with diabetes and may 
affect self-care abilities and health outcomes (Kirkman 
et al, 2012). This greatly increases the risk of 
medication-related problems and adverse events in 
these patients. 
Medication reconciliation is a five step process of 
coming up with a list of a patient’s current medications 
that is as complete and accurate as possible and then 
comparing the medications with those in the provider 
medication orders and should be conducted during 
transitions of care such as changes in clinical setting, 
practitioner or level of care in which new medications 
are ordered or existing orders are rewritten (Cameli et 
al, 2012).  The process of reconciliation has been 
demonstrated to be a powerful strategy to reduce ADEs.  
Medication reconciliation at admission leads to a 
significant reduction in actual ADEs (Boockvar et al, 
2011).  There was a reduction in potential ADEs within 
three months of implementation when pharmacy 
technicians were used to initiate the process of 
reconciliation in surgical population (Michels and 
Meisel,  2003). 
In a study by Vira, 60% of participants had at least one 
unintended discrepancy and 18% had at least one 
clinically significant discrepancy. A medication 
reconciliation process intercepted about 75% of the 20 
clinically significant discrepancies before patients were 
harmed (Vira, Colquhoun, and Etchells, 2006).  
Omission or addition of a medication to the patient's 
medical record are the most frequent types of 
medication discrepancies and are common to all three 
points of care, admission, transfers within hospital units 
and discharge (Azzi et al, 2014).   
Issues with regard to management of medication in the 
treatment of diabetes have been well documented, 
however less is known about the prevalence and 
predictors of medication discrepancies associated with 
diabetic patients 60 years of age and older at admission 
in hospitals in Kenya. The aim of this study was to 
determine the prevalence and risk factors for 
medication discrepancies at admission of inpatient 
elderly diabetics at Kenyatta National Hospital (KNH). 
2. Methods 
2.1 Study Design and Site 
The design was a cross sectional study involving elderly 
diabetic patients hospitalized at Kenyatta National 
Hospital from January to May 2016. KNH is the largest 
National Teaching and Referral hospital in Kenya. There 
were a total of 422 elderly diabetic participants 
admitted to the wards in the year 2014 and 238 elderly 
diabetics in the first half of 2015. The number of 
diabetic participants attending clinic at KNH diabetes 
clinic in the year 2014 was 2763 and in 2015 up to June 
was 1867. 
2.2 Study Population and Eligibility Criteria 
The study population was elderly diabetic participants 
who were admitted to the medical wards at KNH in 
2016. Elderly diabetic patients were defined as patients 
that were 60 years of age and older who were on insulin 
or oral hypoglycaemic drugs. Voluntary informed 
consent was obtained from the participants.  Proxy 
consent was required if participant was too ill, had no 
knowledge of their medications and there was a 
language barrier.  Participants who declined to give 
consent or were comatose were excluded from the 
study. 
2.3 Sample Size Determination 
The sample size was based on the estimates of the 
prevalence of medication discrepancies for participants 
on admission to hospital according to Cornish et al 2005 
who found a 60% discrepancy rate. Sample size was 
calculated using the Hulley formula (Hulley et al, 2007).  
The calculated minimal size was approximately 148 
patients. The calculated sample size was inflated by 
10% inflation to cater for poor response during data 
collection giving a final sample size of 163 participants. 
2.4 Sampling Method and Participant Recruitment 
Convenient sampling was conducted where every 
participant who met the inclusion criteria was recruited 
a day after admission in order to allow for standard care 
to take place. A list of patients who had a history of 
diabetes and were admitted within 48 hours was 
obtained from the admission register on the date of 
recruitment. Files of these patients were perused to 
identify patients who met the inclusion criteria. Patients 
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were recruited in the afternoons when there was 
reduced work in the wards or after ward rounds. For 
patients who were too ill or only spoke their mother 
tongue, the next of kin were interviewed during visiting 
hours.  
2.5 Data Collection and Reconciliation 
The list of the participants who accepted to take part in 
the study and who met the inclusion criteria was 
obtained. The files were retrieved and the following 
information obtained: the sociodemographic traits, 
admission day, and admission time, diagnosis at 
admission, medication history, comorbidities and 
medication list on admission.  
Best Possible Medication Histories (BPMH) was 
obtained using the aid of questionnaires.  Additional 
methods were used because it was anticipated that 
participants would have poor knowledge of their 
medications. A list of medications used at home prior to 
admission was obtained. The patient was then 
requested to ask his caregivers to bring his home 
medications in the next visit if he did not have them 
with him at the time of the interview.  For participants 
with poor knowledge of drugs or those who could not 
speak English or Kiswahili, the research pharmacist 
then interviewed the caregivers during visiting hours. 
Questions were asked on use of prescription, over the 
counter and herbal medication. The total number, name 
/brand and doses of drugs the patient was taking prior 
to admission were noted.  
A comparison was made between the list of drugs used 
prior to admission and that of the admission list in the 
participant’s file. Each participant’s pre admission and 
admission medications were studied for discrepancies 
and categorized by the investigator with the help of 
clinicians who agreed to take part in the study. An 
attempt made to correct any errors as soon as possible.  
The prescribers’ names and contacts were obtained 
from patient files and the ward in charge of the various 
wards. An interview was then set up with each of the 
clinicians so as to determine if the discrepancies were 
intentional or not. Consent was obtained from 
prescribers prior to an interview.  Five clinicians agreed 
to take part in the study and were made aware of the 
discrepancies identified by the investigator. The 
discrepancies were classified as intentional, 
undocumented intentional and unintentional.  
Medication discrepancies for which no clinical rationale 
could be identified (unintentional changes) were 
concluded to be medication errors.  
2.6 Study Variables  
The main outcome variable was the number of 
discrepancies between preadmission and admission 
medications. Medication discrepancies were any 
differences that were intentional or unintentional, 
between the diabetes-related medication list in the 
patient's file, and the diabetes-related medications 
reported by the patient during the medication use 
interview. Any additions, omissions and dose changes of 
drugs in the hospital admission medication list were 
considered medication discrepancies. 
The dependent variables of interest were: age, sex, 
ward, marital status, job status, poly-pharmacy, 
comorbidities, cadre of admitting clinician, education 
level, time of admission, discharge forms from previous 
facility, and management of own medication. 
2.7 Statistical Analysis 
Continuous data was summarized in form of means, 
standard deviations, medians and interquartile ranges 
(IQR). Categorical data was summarized as counts and 
percentages. The total number of discrepancies was 
regressed against its covariates. Those variables whose 
p value was less than 0.05 and also those with high 
clinical impact were considered for multivariable linear 
regression analysis with robust estimation. This was 
used to adjust for confounding as well. Linear 
regression analysis with robust estimation was carried 
out using SPSS version 21 software. Backward stepwise 
model building was done to come up with a 
parsimonious model. The level of significance was set at 
0.05. 
Table 1: Baseline characteristics of study participants  
Characteristic n=163(%) 
Age   60-64 60 (36.8) 
65-69 41 (25.2) 
70-74 28 (17.2) 
75-79 20 (12.3) 
80-84 5 (3.1) 
>84 9 (5.5) 
Sex Male 82 (50.3) 
Female 81 (49.7) 
Wards 7A 31(19.0) 
7B 20 (12.3 
7D 26(16.0) 
8A 31(19.0) 
8B 28(17.2) 
8D 25(15.3) 
Marital status Single 16 (9.9) 
Married 122 (75.3) 
Divorced 6 (3.7) 
Widowed 18 (11.1) 
Education level Primary 119 (73.0) 
Secondary 38 (23.3) 
Certificate 1(0.6) 
Diploma 3 (1.8) 
Degree 2 (1.2) 
Job status Employed 12 (7.5) 
Self-
employed 
80 (49.1) 
Retired 22 (13.5) 
Other 5 (3.1) 
Unemployed 44 (27.0) 
 *Wards 7C and 8C had only one participant each. 
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2.9 Ethical Considerations 
Approval to carry out the study was obtained from the 
Kenyatta National Hospital/ University of Nairobi 
Research and Ethics Committee in November 2015 
approval number KNH-ERC/A/470, prior to 
commencement of the study.  
Informed consent was obtained from participants and 
proxy consent obtained from caregivers of patients who 
were too ill, had no knowledge of their medications and 
could not communicate in English or Kiswahili. Consent 
from the admitting clinicians was also obtained.  
To ensure confidentiality, unique patient numbers 
rather than patient names or outpatient numbers were 
used. 
 
3. Results  
During the three and a half month study, 183 T2DM 
elderly patients were screened for eligibility, of these, 
163 met the inclusion criteria. Twenty patients were 
excluded for the following reasons: 3 were discharged 
home before an interview could be carried out; 5 
declined consent; 8 died before a medication use 
interview; and 4 were not on any antidiabetic 
medication.  The characteristics of the 163 participants 
are summarized in Table 1. Most of the participants 
were aged between 60 and 64 years (36.8%, n=60).  As 
age increased, the number of participants declined. The 
median age was 67 years [62-73].  Nearly half, 50.3% of 
the participants were male. About three quarters 
(75.3%) of the participants were married.  Most (73%) 
had attained primary level education and 49.1% were 
self-employed in farming. 
       Table 2: Comorbidities and Medical History of study participants 
Comorbidities n % 
Hypertension 131 80.4 
Cardiovascular 26 16.0 
End Stage Renal Disease 22 13.5 
Chronic Renal Disease 20 12.3 
Cancer 12 7.4 
Retroviral Disease 5 3.1 
Epilepsy 3 1.8 
Asthma 3 1.8 
Liver Disease 2 1.2 
Parkinsonism 2 1.2 
Arthritis 1 0.6 
Medical history   
Years since diagnosed 1-5 years 44 27.2 
5-10 years 36 22.2 
10-15 years 42 25.9 
>15 years 40 24.7 
Attendance of clinic Monthly 99 60.7 
Every 3 months 39 23.9 
Never 19 11.7 
 Other 6 3.7 
Attendance of clinic for 
comorbidities 
Yes 122 74.8 
No 22 13.5 
No comorbidities 19 11.7 
Diagnosis at Admission    
Diabetic foot  21 12.9 
Heart disorders  17 10.4 
End organ damage  11 6.7 
Respiratory infections  11 6.7 
Sepsis  10 6.1 
 
 
  
Okerosi et al, Afr. J. Pharmacol. Ther. 2017. 6(1): 54-63 
 
A KeSoBAP Publication ©2017. All rights reserved. 
58 
Participant Medical Information 
A large number of the participants were admitted at 
night from 8 p.m to midnight (30.1%, n=49); followed 
by the wee hours of the morning which was midnight to 
6 a.m (23.9%, n=39). Senior health officers/ registrars 
were the most common admitting clinicians (80.6%, 
n=108). About half, 50.9%, of the patients were 
admitted from home and the most common diagnosis at 
admission was diabetic foot (12.9%, n=21). Table 2 
summarizes the medical information of the study 
participants. 
Nearly 80%, (131) had hypertension. Only one 
participant had arthritis. Other comorbidities are as 
shown in Table 2. From the past medical history taken, 
27.2% of the patients were diagnosed 1-5 years ago and 
a large proportion were attending clinic for diabetes 
(60.7%) and other comorbidities (74.8%).  Majority of 
the participants (82.7%) managed their own 
medication. The rest had a family member manage their 
medication intake and storage (Table 2). 
Patterns of Medicine use among the Participants 
A total of 112 (68.7%) participants were on metformin 
prior to admission; 68 (41.7%) were on insulin 70/30; 
and 54 (33.1%) were on glibenclamide. The use of 
glibenclamide is a medication error as it is discouraged 
in elderly persons. About 35% of the participants were 
put on soluble insulin on admission. Only six were put 
on Insulin 70/30 upon admission. 
For participants with hypertension as comorbidity, 
enalapril (27%, n=44) was the most commonly used 
drug prior to admission followed by nifedipine (20.2%, 
n=33) and lastly amlodipine (18.4%, n=30) (Table 3). 
On admission, enalapril was also the most commonly 
prescribed drug; 15 patients were put on this drug. 
Twelve participants were prescribed nifedipine. 
Participants with other comorbidities had an additional 
215 medications in total prior to admission. On 
admission, an additional 422 medications were given to 
participants for various medical reasons.  
   Table 3: Patterns of Medicine use among the Elderly Participants 
Drug Classes Medication used at 
home 
Number of 
participants 
n (%) 
Medications added 
on admission 
Number of 
participants 
n (%) 
Hypoglycemic Agents Insulin 70/30 68(41.7) Soluble insulin 57 (35.0) 
Metformin 112 (68.7) Insulin 70/30 6 (3.7) 
Glibenclamide 54 (33.1) Metformin 1 (0.6) 
Glimepride 2 (1.2)   
Gliclazide 5 (3.1)   
Saxagliptin 2 (1.2)   
Chlorpropramide 1(0.6)   
Antihypertensive Drugs 
ACE inhibitors Enalapril 44 (27.0) Enalapril 15 (9.2) 
Calcium Channel 
blockers 
Nifedipine 33 (20.2) Amlodipine 7 (4.3) 
 Amlodipine 30 (18.4) Nifedipine 12 (7.4) 
   Nimodipine 1 (0.6) 
Beta blockers Atenolol 13 (8.0) Atenolol 2 (1.2) 
 Propranolol 2 (1.2)   
 Metoprolol 2 (1.2)   
 Nebivolol 3 (1.8)   
Alpha and Beta 
blocker 
Carvedilol 20 (12.3) Carvedilol 6 (3.7) 
Alpha 2 adrenergic 
receptor antagonists 
Methyldopa 4 (2.5) Methyldopa 1 (0.6) 
Angiotensin II 
receptor antagonists 
Losartan 16 (9.8) Losartan  7 (4.3) 
 Losartan/ 
Hydrochlorothiazide 
21 (12.9) Losartan/ 
Hydrochlorothiazide 
4 (2.5) 
 Telmisartan/ 
Hydroclorothiazide 
2 (1.2) Telmisartan 1 (0.6) 
Vasodilators Hydralazine 2 (1.2) Hydralazine  5 (3.1) 
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The Medication Reconciliation process and 
Prevalence of Medication Discrepancies  
The Best Possible Medication History (BPMH) was 
obtained from various sources, and from this, a pre-
admission medication list was generated. The most 
common source was patient/caregiver interview 
(100%, n=163). 
This was followed by the medication history in the 
participants’ files written by the provider (97.5%, 
n=159). Only 15.3% had their medication with them for 
reconciliation. Most patients’ medications were 
reconciled 24 hours after admission (47.9%, n=78). 
Then 69(42.3%) patients had their medications 
reconciled 2 to 3 days after admission. Only 16(9.8%) 
patients had their medications reconciled 4 to 12 days 
after admission. 
On reconciliation of the 163 patients’ medication, 1089 
medication discrepancies were identified. The mean 
number of discrepancies per participant was 6.68 ± 2.4. 
Only one patient had no medication discrepancy.  
Approximately 16% (n=27) of the participants had a 
total of 6 medication discrepancies each.  The most 
common class of drugs with discrepancies was 
antidiabetic drugs (37.9%, n=91). Others include 
antihypertensive drugs, diuretics, lipid lowering drugs 
like atorvastatin, cardiac glycosides like digoxin and 
anti-platelets among others. 
Classification of medication discrepancies is presented 
in Figure 1. Classification was done as described by 
Pippins et al (2008), as summarized below: 
Omissions: absence of a patient’s prescribed 
medication from a prescription. 
Dose Changes: changes to the doses of a patient’s 
prescribed medication. 
Additions: extra medication prescribed in a patient’s 
prescription. 
Duplications: repetition of a medication(s) in a 
patient’s prescription. 
 
 
 
Figure 1: Classification of medication discrepancies detected 
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Of the medication discrepancies, 849 were intentional 
and of these 19% of them were undocumented; a mean 
number of one undocumented discrepancy per 
participant. The remaining discrepancies (22%, n=240) 
were unintentional discrepancies. Omissions were the 
most common unintentional discrepancies (98.3%, 
n=236), while 0.4% were dose changes (n=1) and 1.3% 
were additions (n=3). The unintentional discrepancy 
per participant was 1.5. There were no therapeutic 
duplications. One hundred and three patients (63.2%; 
95% CI, 55.6%-70.3%) had at least one unintentional 
discrepancy. Of the 103, 35.9% had only one 
unintentional discrepancy (n=37). Majority (55.3%, 
n=57) had 2-4 discrepancies; nine (8.7%) had more 
than 4 discrepancies. 
Among the unintentional discrepancies, 94% were 
judged to have potential for harm (n=225). Only 42% 
were resolved. An example of a discrepancy with a 
potential for harm was the omission of metformin, 
insulin 70/30 among others from the admission orders 
with no clinical rationale. The most common drug 
classes of medications for which there were 
unintentional discrepancies were antidiabetic (37.9%, 
n=91), antihypertensive (24.2%, n=58) and diuretic 
drugs (8.3%, n=20). All these are Class A drugs that are 
essential; their omission can be potentially harmful.  
Risk factors for Medication Discrepancies 
Descriptive analysis carried out showed that wards 7A 
with a mean number of discrepancies of 8 (SD 3), 7D 
and 8B with a mean number of discrepancies of 7 (SD 2) 
had the highest number of discrepancies; most likely 
this was due to the high number of participants from 
each of these wards. Participants with 3 comorbidities 
had the most medication discrepancies with a mean of 
8(SD 2).  
Another observation of interest was that most 
discrepancies occurred in the morning (approximately 
8 discrepancies per participant). Those who had more 
than 10 medications prior to admission also had the 
highest number of medication discrepancies a mean of 
9(SD 3).  
Participants with hypertension and cancer had a mean 
number of discrepancies of 7(SD 2), those with 
retroviral disease had a mean number 9(SD 2) and end 
stage renal disease a mean number of 8(SD 3) 
Participants with these comorbidities had the most 
discrepancies.  Bi-variable linear regression analysis 
was carried out with the number of medication 
discrepancies as the dependent variable Table 4.  
  Table 4: Regression analysis for determination of possible predictors to medication discrepancies 
Variables 
Bi-variable Regression Analysis 
Parsimonious Multivariable 
Regression Analysis 
Crude β coefficients Adjusted β coefficients 
β (95% CI) P value β (95% CI) P value 
Age group -0.667 (-1.245, -0.0896) 0.024 -0.755(-1.284, -0.226) 0.005 
Ward -0.112 (-0.274, 0.049 0.173 - - 
Education Level -0.220 (-0.759, 0.319) 0.422 - - 
Number of comorbidities 0.665 (0.197, 1.133) 0.006 - - 
Hypertension 1.469 (0.539, 2.400) 0.002 0.992 (0.094, 1.890) 0.031 
End stage renal disease 1.735 (0.654, 2.816) 0.002 - - 
Retroviral disease 2.186 (0.005, 4.368 0.05 - - 
Cancer -1.455 (-2.894, -0.015) 0.048 - - 
Asthma 1.683 (-1.137, 4.504) 0.24 - - 
Discharge forms from 
previous facility 
0.615 (-0.147, 1.377) 0.113 0.701 (0.010, 1.392) 0.047 
Number of previous 
medication 
1.488 (0 .880, 2.096) <0.0001 1.377 (0.767, 1.987) <0.0001 
Management of own 
medication 
-0.712(-1.713, 0.289) 0.162 - - 
Time of admission 0.029(-0.211, 0.268) 0.813 - - 
 
On multivariable linear regression analysis, the number 
of medications prior to admission, and having 
hypertension as comorbidity were significant 
predictors for medication discrepancies at admission. 
There was a negative association between increasing 
age and medication discrepancies; participants who 
were younger were in this case found to be more likely 
to have medication discrepancies (adjusted β coefficient 
-0.755 (95% CI: -1.284, -0.226)); this was statistically 
significant (p=0.005). Participants with hypertension 
were more likely to have medication discrepancies than 
those without hypertension (adjusted β coefficient 
0.992 (95% CI: 0.094, 1.890)).  For every unit increase 
in the number of medications given before admission, 
the number of medication errors per patient increased 
by 1.4 units. Those with many medications prior to 
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admission were more likely to have medication 
discrepancies than those with fewer medications on 
admission (adjusted β coefficient 1.377 (95% CI: 0.767, 
1.987)).  Those with information on their drug usage 
from discharge forms from previous facilities 
interestingly showed a positive relationship with the 
number of medication discrepancies (adjusted β 
coefficient 0.701 (95% CI: 0.010, 1.392)).  Therefore the 
number of previous medication, hypertension and those 
with discharge forms from other facilities were 
significant predictors of the number of medication 
discrepancies. 
4.0 Discussion 
In the study population of elderly diabetics, all but one 
of the patients had medication discrepancies following 
medication reconciliation. On classification of the 
discrepancies, 63.2% of the patients (95% CI 55.6-70.3) 
experienced at least one unintentional discrepancy. The 
findings were far greater than other studies probably as 
a result of different conceptualization, definitions and 
methods. One study showed that at least about 60% had 
at least one unintentional discrepancy (Vira et al, 2006). 
Other studies found about half of participants had at 
least one unintentional discrepancy (Cornish et al, 2005 
and Hellström et al, 2012).  
The most common unintentional discrepancy/error was 
an omission of a medication the participant reported 
taking before admission (n=236, 98.3%). This was 
consistent with other studies that also showed that 
omissions were the most common unintended 
discrepancy (Cornish et al, 2005; Hellström et al, 2012; 
Quélennec et al, 2013).   
About 94% of the unintentional discrepancies had the 
potential for harm.  This prevalence of unintentional 
medication discrepancies with potential for harm was 
1.4 per participant and this was similar to a study that 
also reported an average of 1.4 per patient (Pippins et 
al, 2008).  It is important to note that some studies use 
medication discrepancies to mean the same as 
medication errors; however in this study the two 
concepts are different. Unintentional discrepancies in 
this study are the errors and specifically reconciliation 
errors. 
The most common drug classes involved in 
unintentional discrepancies were antidiabetic (37.9%, 
n=91), antihypertensive (24.2%, n=58) and diuretic 
drugs (8.3%, n=20). This has a clinical impact on 
management of diabetic patients more so those with 
hypertension as comorbidity. This finding is in contrast 
to a study that identified nervous system (22.0%), 
gastrointestinal (20.0%) and cardiovascular (18.0%) 
medications as the most common drugs involved; 
however the study was not conducted only on elderly 
diabetic patients (Quélennec et al, 2013).  
The results showed, wards with high density of medical 
cases had higher number of discrepancies.  Those 
admitted in the morning between 6.00 am and 11.59a.m 
had the most discrepancies. The probable reason why 
most discrepancies occurred at this time could be 
because this is a busy time when ward rounds are being 
conducted and the quality of care may decline. The 
higher the number of comorbidities a patient had, the 
higher the number of discrepancies. 
Risk factors for the occurrence of medication 
discrepancies included an increased number of 
preadmission drugs and hypertension as comorbidity. 
There was a linear relationship between the number of 
medications prior to admission and the number of 
discrepancies (P < 0.0001) and this was similar to 
studies by Stitt et al (2011) and Hellstom et al (2012).  
This relationship is not surprising and was expected. A 
study in 2008 contradicted this finding (Pippins et al, 
2008). 
Older age showed a negative correlation to medication 
discrepancies, in that, the younger age was associated 
with more medication discrepancies. Stitt et al (2011) 
showed no relationship between age and the number of 
medication discrepancies.  This finding contrasted 
another that found that older age as a significant 
predictor to medication discrepancies. This again could 
be due to the different definitions and use of medication 
discrepancies and medication errors. The differences 
noted in general could be due to fewer ward 
pharmacists in Kenya compared to the west. It is also 
probable that clinicians paid greater attention to older 
patients, hence, fewer errors. 
A positive association was found between hypertension 
and medication discrepancies. There was however no 
studies showing this association. This could be the first 
of them. The variables end stage renal disease (ESRD), 
retroviral disease (RD) and cancer may not have shown 
statistical significance but showed clinical significance 
in that, participants with these comorbidities had more 
medication discrepancies.  It is of clinical importance to 
note that these participants are more likely to have 
medication discrepancies compared to those without 
these comorbidities. There are however no studies 
supporting this clinical significance. This could be the 
first. 
The study showed that those with discharge forms from 
previous facilities were also more likely to have 
medication discrepancies. This not only showed 
statistical significance but clinical significance. This 
could be an indication of the lack of accurate discharge 
summaries and not just inaccurate medication histories. 
Several studies have been done that show a high 
discrepancy rate at discharge (Wong et al, 2008; Nelson 
et al, 2011; Geurts et al, 2013). There was however no 
studies to support this as risk factor to medication 
discrepancies at admission. 
The findings from this study have significant 
implications for practice as they showed that those 
participants with hypertension, an increased number of 
medications prior to admission and discharge 
summaries from previous facilities could benefit most 
from medication reconciliation at admission.  As a 
starting point medication reconciliation should focus on 
patients with high number of drugs prior to admission 
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and those diabetics with hypertension since results 
showed these as key predictors to medication 
discrepancies.  Pharmacists, physicians, nurses, and 
patients play a key role in this process. Pharmacists 
especially are central to medication reconciliation and 
are responsible for identification and resolving errors 
with collaboration from the physicians, nurses and the 
patients themselves. However, an adequate system of 
rectification of errors is needed. A reconciliation tool 
should be developed specific for an institution and 
reconciliation done after admission by the hospital 
pharmacist. 
Further study needs to be done on the clinical impact of 
unintentional discrepancies more so those with the 
potential for harm. Future studies can include nurses 
and not just prescribers. Medication reconciliation 
would need to be carried out on other vulnerable 
groups such as pregnant women, those on high risk 
medication among others. There are no other studies in 
Kenya and Africa on medication discrepancies. This is 
the first and will provide baseline data for future study 
in this area. The strength of this study is that it also 
highlighted the critical role a pharmacist can play in 
preventing patient medication errors through 
medication reconciliation.  
There were limitations to this descriptive study. First, it 
was conducted only in the internal medicine wards of a 
single hospital limiting its generalizability. Secondly, 
there is currently no gold standard for the identification 
of medication use at home. Therefore an assumption 
was made that the drugs the patient or caregiver gave 
as drugs used prior to admission were the accurate 
drugs being used. This limitation was mitigated by using 
various sources to obtain medication history. Thirdly, 
the classification of the discrepancies into intentional, 
undocumented intentional and unintentional partly 
relies on subjective judgement and is therefore subject 
to bias. One could argue that undocumented intentional 
medication discrepancies represent “latent” medication 
errors that could lead to harm. Lastly there was a 
likelihood of Hawthorne bias that resulted from 
clinicians’ awareness of the researcher’s presence in the 
wards. This was managed by using the research 
assistant to collect data and collection of data randomly 
across the wards and at different times.  
5.0 Conclusion  
A total of 1089 medication discrepancies were 
identified and classified into intentional and 
unintentional discrepancies. Omissions were the most 
commonly occurring type of discrepancies. A high 
number of these discrepancies had the potential to 
cause harm and only 42% were resolved.  Hypertension, 
increased number of medication prior to admission, and 
discharge summaries from previous facilities were 
significant predictors of medication discrepancies. 
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